CYP2C19. - Globe Thesis

Keyword [CYP2C19.] Result: 161 - 180 \| Page: 9 of 10
161.	Polymorphisms Of Clopidogrel Metabolism-related Genes In The Population Of Zhangzhou And Analysis Of Platelet Reactivity And Drug Awareness After Administration
162.	Association Of Clopidogrel Metabolism Related Genetic Polyrmorphisms With Platelet Reactivity And Ischemic Events Among Patients With Ischemic Stroke
163.	The Individualized Treatment Of Antiplatelet Agents On Patients Of Different CYP2C19 Genotypes Under The Guidance Of Thromboelastogram
164.	Comparative Study Of Prognosis Improvement From Precision Antiplatelet Therapy And Artificial Neural Network In Patients After PCI
165.	Correlation Of CYP2C19 Genotype And Cardiovascular Outcomes Of Clopidogrel Treatment Among Chinese Patients With Coronary Heart Disease Receiving Coronary Stent Implantation
166.	Study On The Treatment Effect Increasing Mechanism Of Combining The Prescription Of Building Up Vital Energy And Nourishing The Blood With Omeprazole On Peptic Ulcer Based On The CYP2C19 Genetic Polymorphism
167.	Research On Anti-platelet Drugs In ACS Patients With CYP2C19 Intermediate Metabolizer Receiving PCI And The Underlying Mechanisms
168.	Effects Of Individualized Antiplatelet Therapy Based On CYP2C19 Genotype And Platelet Function On The Prognosis Of Patients After PCI
169.	Association Of CYP2C19 Loss-of-function Variants And P2Y12 H2 Haplotype With High On-treatment Platelet Reactivity And Clinical Outcome In Ischemic Stroke
170.	Exploration Of Clinical Predictive Model Of HTPR To Clopidogrel And The Relationship With PDI、T2DM
171.	Correlation Analysis Of Clopidogrel Metabolism-related Gene Polymorphisms And Adverse Events In Patients With Acute Coronary Syndrome
172.	Study On The Risk Factors Of Clopidogrel Resistance In Patients With Atherosclerosis
173.	Clinical Study Of Clopidogrel Resistance And CYP2C19 Gene Polymorphism In Patients With Diabetic PCI
174.	Association Of CYP2C19 Gene Polymorphisms In Patients With Cerebrovascular Disease
175.	Analysis Of CYP2C19 Polymorphism In Patients With Poor Inhibition Of Platelet Aggregating Function
176.	The Value Of CYP2C9 And CYP2C19 Gene Polymorphisms In Guiding Clinical Application Of Cardiovascular Drugs
177.	Risk Factors Affecting In-stent Restenosis After Carotid Artery Stenting And Clopidogrel Drug-related Gene (CYP2C19) Mutation
178.	A Study On The Prognosis Of Patients With CYP2C19 Slow Metabolism After After Percutaneous Coronary Intervention
179.	Influence Of CYP2C19 Gene Polymorphism On The Prognosis Of Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
180.	The Influence Of CYP2C19 Gene Polymorphism And CHD Risk Factors On Clopidogrel Resistance And The Retrospective Analysis Of The Effect Of CYP2C19 Gene On Rational Use Of Antiplatelet Agents After PCI
<<First <Prev Next> Last>> Jump to